Wednesday, August 26, 2026

Strategy's mNAV Falls Below 1, Forcing Bitcoin Treasury Overhaul

Strategy's market-to-net-asset-value premium dropped below 1, signaling investors no longer trust its leveraged Bitcoin-accumulation model. The company hiked its STRC preferred dividend to 12%, authorized a $2 billion buyback, and launched a monetization program as Bitcoin ETFs saw $4 billion in monthly outflows.

LM Salvado
LM Salvado

July 16, 2026

Strategy's mNAV Falls Below 1, Forcing Bitcoin Treasury Overhaul
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.
Loading stream...

Strategy's mNAV premium fell below 1 this month, the clearest signal yet that markets have stopped rewarding the company's leveraged Bitcoin-accumulation playbook.1 The metric compares Strategy's market value to the net asset value of its Bitcoin holdings; a reading below 1 means investors are pricing the stock at a discount to its crypto stash, not a premium.

Strategy, formerly MicroStrategy and still the largest corporate holder of Bitcoin, responded by restructuring its capital plan.1 The company raised its STRC preferred dividend to 12% to retain capital, authorized a $2 billion share buyback, and overhauled its financing framework to move beyond pure Bitcoin accumulation. It also launched a monetization program, a shift from its years-long buy-and-hold strategy.1

Michael Saylor, the company's co-founder, sold a small amount of Bitcoin, a departure from his public commitment to never sell.1 The move coincided with a broader pullback: Bitcoin ETFs recorded $4 billion in outflows over the past month, pointing to cooling institutional appetite for crypto exposure.1

Regulators are adding pressure of their own. The Bank for International Settlements, in its annual report, cast doubt on stablecoins' status as money.1 "The stable coins show redemption frictions, which we've literally never seen and trade off par... resemble more like ETF shares. They're not a means of payment. They don't settle on central bank balance sheets and can't guarantee par across issuers," the BIS said.1

The BIS also flagged dollar stablecoins as a risk to weaker economies. "Dollar stable coins are accelerating dollarization in fragile economies, weakening local currencies, and dodging capital controls because you can't enforce border rules on a self-custodied token," the report said.1

Together, the mNAV collapse and the BIS warning mark a turning point for crypto-adjacent corporate finance. The leveraged treasury model that fueled Strategy's rise now faces its first real test, just as regulators signal tighter scrutiny of the stablecoin infrastructure underpinning much of the crypto market.1

Source documents

Via News is a conduit. We point to the source documents behind this report — we don't replace them. Trace any claim to its source and decide what to trust. How we source

Source Trace Score1 source document1 with a live linkVerifiability: Basic
  1. [1]News articleYahoo Finance· June 29, 2026
    Saylor's Strategy changes playbook and can now sell its bitcoin

In this story · Knowledge Files

LM Salvado
LM Salvado

LM Salvado is an AI possibilist — he takes the risks of AI seriously, and still sees the route through them. Founder of Via News Network, an AI-native newsroom built on full source-traceability, he tracks how AI is reshaping markets, capital, and labor — the quiet shifts that happen before the headlines catch up.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com